Paul Hopper

Paul Hopper

Founder bei IMUGENE LIMITED

Vermögen: 30 Mio $ am 31.03.2024

68 Jahre
Health Technology
Finance
Commercial Services

Profil

Paul A.
Hopper
is the founder of Prescient Therapeutics Ltd.
(founded in 1986) and Imugene Ltd.
(founded in 2012).
He is also the founder of Chimeric Therapeutics Ltd.
(founded in 2020).
Currently, Mr. Hopper holds the position of Chairman at Vaxinia Pty Ltd., Executive Chairman at Radiopharm Theranostics Ltd., Managing Director at Cappello Group, Inc., Director at Biolife Science Ltd., President & Director at Radiopharm Theranostics (USA), Inc., MD, Head-Life Sciences & Biotechnology Group at Cappello Global LLC, and Member at Pacific Council on International Policy.
In his former positions, Mr. Hopper served as Executive Chairman at CAQ Holdings Ltd., Viralytics Pty Ltd., and Botanix Pharmaceuticals Ltd.
He was also the Executive Chairman at Arovella Therapeutics Ltd.
from 2019 to 2022.
Additionally, he held various roles such as Chairman-California Chapter at American Australian Association, Executive Chairman at Bioscience Oncology Pty Ltd., Director at Fibrocell Science, Inc., Director at Advanced Biotherapy, Inc., Independent Non-Executive Director at Somnomed Ltd., Director at Medaire Ltd., Chief Operating Officer & Director at Acuvax Ltd., Independent Director at EyePoint Pharmaceuticals, Inc., Non-Executive Director at Respiri Ltd., Managing Director at Avantogen Ltd., Independent Director at Scopus Biopharma, Inc., and President at Innovate Oncology, Inc. Mr. Hopper's education includes an undergraduate degree from The University of New South Wales.
Mr. Hopper is also the founder of Pathway Oncology Pty Ltd., Glioblast Pty Ltd., Polynoma LLC, and Alpha Healthcare Ltd...

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
19.04.2024 408 096 531 ( 5,58% ) 28 Mio $ 31.03.2024
21.09.2023 94 137 432 ( 11,12% ) 2 Mio $ 31.03.2024
25.11.2022 423 521 ( 0,10% ) 15 471 $ 31.03.2024

Aktive Positionen von Paul Hopper

UnternehmenPositionBeginn
IMUGENE LIMITED Founder 31.10.2012
CHIMERIC THERAPEUTICS LIMITED Founder 02.02.2020
RADIOPHARM THERANOSTICS LIMITED Chairman 11.02.2021
Chairman -
Director/Board Member -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal 01.11.2005
President -
Alle aktiven Positionen von Paul Hopper

Ehemalige bekannte Positionen von Paul Hopper

UnternehmenPositionEnde
░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Paul Hopper im Detail an

Ausbildung von Paul Hopper

The University of New South Wales Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Paul Hopper im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

33

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen11
SOMNOMED LIMITED

Health Technology

CAQ HOLDINGS LIMITED

Finance

PRESCIENT THERAPEUTICS LIMITED

Health Technology

IMUGENE LIMITED

Health Technology

BOTANIX PHARMACEUTICALS LIMITED

Health Technology

EYEPOINT PHARMACEUTICALS, INC.

Health Technology

AROVELLA THERAPEUTICS LIMITED

Health Technology

RESPIRI LIMITED

Health Technology

SCOPUS BIOPHARMA INC.

Health Technology

CHIMERIC THERAPEUTICS LIMITED

Health Technology

RADIOPHARM THERANOSTICS LIMITED

Health Services

Private Unternehmen21

Health Technology

Finance

Finance

Retail Trade

Health Technology

Health Technology

Finance

Innovate Oncology, Inc.

Health Technology

Commercial Services

Commercial Services

The Merchants Bank of New York

Finance

Health Technology

Avantogen Ltd.

Commercial Services

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

C19 Therapeutics Pty Ltd.

Bioscience Oncology Pty Ltd.

Health Technology

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Paul Hopper